Published in Cancer Weekly, February 7th, 2012
"Therefore, negative regulator of VHL may be a good target for regulating NF-'B and IGF-1R....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.